Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the use of ketamine in psychiatric practice

被引:0
作者
Hussain, Salam [1 ,2 ,3 ,4 ]
Gale, Chris
Sarma, Shanthi [5 ,6 ]
Smith, Jeremy [7 ]
Bayes, Adam [8 ,9 ]
Loo, Colleen [8 ,9 ,10 ,11 ]
机构
[1] Royal Australian & New Zealand Coll Psychiatrists, Sect Electroconvuls Therapy, Melbourne, Vic, Australia
[2] Royal Australian & New Zealand Coll Psychiatrists, Neurostimulat Binatl Comm Chair, Melbourne, Vic, Australia
[3] Univ Western Australia, Fac Hlth & Med Sci, Sch Psychiat, Perth, WA, Australia
[4] Sir Charles Gairdner Hosp, Mental Hlth Serv, Perth, WA, Australia
[5] Gold Coast Hosp & Hlth Serv, Gold Coast, Qld, Australia
[6] Bond Univ, Gold Coast, Qld, Australia
[7] Southern Inst Neuropsychiat & Aged Psychiat SINAPS, Older Persons Mental Hlth Serv, Hobart, Tas, Australia
[8] Univ New South Wales, Discipline Psychiat, Sydney, NSW, Australia
[9] Black Dog Inst, Randwick, NSW, Australia
[10] George Inst Global Hlth, Barangaroo, NSW, Australia
[11] Ramsay Clin Northside, St Leonards, NSW, Australia
关键词
Guidelines; ketamine; psychiatric disorders; professional practice; depression; TREATMENT-RESISTANT DEPRESSION; ELECTROCONVULSIVE-THERAPY; BIPOLAR DEPRESSION; INTRAVENOUS KETAMINE; RACEMIC KETAMINE; DOUBLE-BLIND; EFFICACY; ANTIDEPRESSANT; DISORDER; SINGLE;
D O I
10.1177/00048674251333577
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Professional practice guidelines for the use of ketamine in psychiatric practice have been developed by the Royal Australian and New Zealand College of Psychiatrists to provide guidance on the use of ketamine in clinical practice in Australia and Aotearoa New Zealand, based on scientific evidence and supplemented by expert clinical consensus. Articles and information were sourced from existing guidelines and published literature. The findings were then formulated into consensus-based recommendations and guidance by the authors. The guidelines were subjected to rigorous successive consultation within the Royal Australian and New Zealand College of Psychiatrists, involving the Section of Electroconvulsive Therapy and Neurostimulation Committee, its broader membership and expert committees. The guidelines are intended for psychiatrists and clinicians engaged in the use of ketamine therapy to facilitate best practice to optimise outcomes for patients. They strive to find the appropriate balance between promoting best evidence-based practice and acknowledging that evidence for ketamine use is continually evolving.
引用
收藏
页数:12
相关论文
共 83 条
  • [1] Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
    Abdallah, Chadi G.
    Roache, John D.
    Gueorguieva, Ralitza
    Averill, Lynnette A.
    Young-McCaughan, Stacey
    Shiroma, Paulo R.
    Purohit, Prerana
    Brundige, Antoinette
    Murff, William
    Ahn, Kyung-Heup
    Sherif, Mohamed A.
    Baltutis, Eric J.
    Ranganathan, Mohini
    D'Souza, Deepak
    Martini, Brenda
    Southwick, Steven M.
    Petrakis, Ismene L.
    Burson, Rebecca R.
    Guthmiller, Kevin B.
    Lopez-Roca, Argelio L.
    Lautenschlager, Karl A.
    McCallin, John P.
    Hoch, Matthew B.
    Timchenko, Alexandar
    Souza, Sergio E.
    Bryant, Charles E.
    Mintz, Jim
    Litz, Brett T.
    Williamson, Douglas E.
    Keane, Terence M.
    Peterson, Alan L.
    Krystal, John H.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 (8) : 1574 - 1581
  • [2] Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients with Treatment-Refractory Depression
    Abuhelwa, Ahmad Y.
    Somogyi, Andrew A.
    Loo, Colleen K.
    Glue, Paul
    Barratt, Daniel T.
    Foster, David J. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 720 - 729
  • [3] Efficacy and safety of ketamine in bipolar depression: A systematic review
    Alberich, Susana
    Martinez-Cengotitabengoa, Monica
    Lopez, Purificacion
    Zorrilla, Inaki
    Nunez, Nuria
    Vieta, Eduard
    Gonzalez-Pinto, Ana
    [J]. REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (02): : 104 - 112
  • [4] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
    Anand, A.
    Mathew, S. J.
    Sanacora, G.
    Murrough, J. W.
    Goes, F. S.
    Altinay, M.
    Aloysi, A. S.
    Asghar-Ali, A. A.
    Barnett, B. S.
    Chang, L. C.
    Collins, K. A.
    Costi, S.
    Iqbal, S.
    Jha, M. K.
    Krishnan, K.
    Malone, D. A.
    Nikayin, S.
    Nissen, S. E.
    Ostroff, R. B.
    Reti, I. M.
    Wilkinson, S. T.
    Wolski, K.
    Hu, B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25) : 2315 - 2325
  • [5] Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial
    Anderson, Ian M.
    Blamire, Andrew
    Branton, Tim
    Clark, Ross
    Downey, Darragh
    Dunn, Graham
    Easton, Andrew
    Elliott, Rebecca
    Elwell, Clare
    Hayden, Katherine
    Holland, Fiona
    Karim, Salman
    Loo, Colleen
    Lowe, Jo
    Nair, Rajesh
    Oakley, Timothy
    Prakash, Antony
    Sharma, Parveen K.
    Williams, Stephen R.
    McAllister-Williams, R. Hamish
    [J]. LANCET PSYCHIATRY, 2017, 4 (05): : 365 - 377
  • [6] Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
    Arabzadeh, Somaye
    Hakkikazazi, Elham
    Shahmansouri, Nazila
    Tafakhori, Abbas
    Ghajar, Alireza
    Jafarinia, Morteza
    Akhondzadeh, Shahin
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 235 : 236 - 241
  • [7] Ketamine for Bipolar Depression: A Systematic Review
    Bahji, Anees
    Zarate, Carlos A., Jr.
    Vazquez, Gustavo H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (07) : 535 - 541
  • [8] Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
    Bahji, Anees
    Vazquez, Gustavo H.
    Zarate, Carlos A., Jr.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2021, 278 : 542 - 555
  • [9] Safety outcomes of ketamine for treatment-resistant depression in clinical settings and development of the ketamine side effect tool-revised (KSET-R)
    Bayes, Adam
    Cao, Thanh Vinh
    Barreiros, Ana Rita
    Massaneda-Tuneu, Clara
    Dong, Vanessa
    Thornton, Nicollette
    Glozier, Nicholas
    Beesley, Laura
    Moreno, Dalia
    Galvez-Ortiz, Veronica
    Short, Brooke
    Martin, Donel
    Loo, Colleen
    [J]. PSYCHIATRY RESEARCH, 2025, 344
  • [10] Ketamine treatment for depression: A model of care
    Bayes, Adam
    Dong, Vanessa
    Martin, Donel
    Alonzo, Angelo
    Kabourakis, Michael
    Loo, Colleen
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (12) : 1134 - 1143